PPARs in the Renal Regulation of Systemic Blood Pressure - Wikidata - wikimedia - TriplyDB

PPARs in the Renal Regulation of Systemic Blood Pressure

PPARs in the Renal Regulation of Systemic Blood Pressure

http://www.wikidata.org/entity/Q33960908

about

Protecting against vascular disease in brain Peroxisome Proliferator-Activated Receptor-α Activation Decreases Mean Arterial Pressure, Plasma Interleukin-6, and COX-2 While Increasing Renal CYP4A Expression in an Acute Model of DOCA-Salt Hypertension.PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome Peroxisome proliferator-activated receptor-γ protects against vascular aging.Impact of Maternal Diet on the Epigenome during In Utero Life and the Developmental Programming of Diseases in Childhood and Adulthood.The renoprotective actions of peroxisome proliferator-activated receptors agonists in diabetes.Angiotensin II blockade: how its molecular targets may signal to mitochondria and slow aging. Coincidences with calorie restriction and mTOR inhibition.Quantitative evaluation of PPAR-γ2 Pro12Ala polymorphism with hypertension.Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis.New Insights Regarding Genetic Aspects of Childhood Obesity: A Minireview

P2860

Q34979773-64C552C7-6578-4EDD-B6AB-964AB92A9D21 Q35608633-BCAC3767-790A-462C-9DA1-218EEF7FA8C7 Q35808814-989D98DE-2B9F-44BA-B224-0E6F3908C36B Q35994295-71A99917-F74C-48E5-9589-C4F83A63EDEA Q36329861-C909CC04-647A-44FD-AF93-36AF53C2251F Q37997004-1A1B3F0F-5A93-434B-9375-E4A577FDA9C0 Q38454084-643E3A56-66D2-463B-A9DB-0FA51512D806 Q47664387-2EEABA8C-562C-44EB-B912-D89CEFCF1939 Q55641730-CC8DBC1E-0EF4-4243-8DC6-468F99B7F3E4 Q58584067-40880E8A-3E78-44CD-8B1D-5662EE0DFB4C

P2860

PPARs in the Renal Regulation of Systemic Blood Pressure

http://www.wikidata.org/entity/Q33960908

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

PPARs in the Renal Regulation of Systemic Blood Pressure

@ast

PPARs in the Renal Regulation of Systemic Blood Pressure

@en

type

label

PPARs in the Renal Regulation of Systemic Blood Pressure

@ast

PPARs in the Renal Regulation of Systemic Blood Pressure

@en

prefLabel

PPARs in the Renal Regulation of Systemic Blood Pressure

@ast

PPARs in the Renal Regulation of Systemic Blood Pressure

@en

P1433

Q33960908-0F716ED0-F379-4833-8FC9-676FE273DD7C

P1476

Q33960908-DA32BC69-53A6-4306-9F78-2A68FC37C0D3

P2093

Q33960908-4880FD66-DCD3-4E7A-800A-D1AF366DE8EE

P2860

Q33960908-01C7DFC9-EFF9-46E8-99E7-CA988B2DBD66

Q33960908-02AFEAA8-2AC0-4BEC-96F4-6D2238FC8980

Q33960908-04E2EFF7-F9D7-4EF0-89F8-EB3E8C6697CE

Q33960908-052BB7AB-C11C-4F76-A82F-CC32197DD86B

Q33960908-06194292-6DD5-4D39-8854-3B815371AF69

Q33960908-09838155-FD7F-4AC5-A09C-59327270CC50

Q33960908-0A6B1CF4-FC81-45D5-9368-9A09E8E8D40F

Q33960908-0A8B159A-320B-4578-AF9F-88696335B027

Q33960908-0DF9F51B-909A-41F5-BC98-6CEF0878A128

Q33960908-111C0B7A-A939-4D8E-8132-7C372252551B

P304

Q33960908-6E2263AE-486A-49C2-B12A-53FED603D76A

P31

Q33960908-959F869C-6817-47C6-BFD8-F529E94E9397

P356

Q33960908-589225DD-48D8-4835-BDD4-51BCFBA36BE6

P478

Q33960908-B1B0ADFC-827B-4C34-8716-B30AC094446F

P50

Q33960908-D19F0726-80C9-402D-9856-81135B63B1FB

P577

Q33960908-34365F89-AF5F-4818-9A44-8B166D9212F4

P5875

Q33960908-C20ABF31-5CAB-4A22-8FA7-169F4FACCCBC

P698

Q33960908-2C40B1F9-0735-41A9-80FA-6A716739C130

P932

Q33960908-8B0C0EB2-7CD8-4CA4-AE69-16E106C322A5

P356

P1433

P1476

PPARs in the Renal Regulation of Systemic Blood Pressure

@en

P2093

Tamás Roszer

http://www.w3.org/2001/XMLSchema#string

P2860

A review of telmisartan in the treatment of hypertension: blood pressure control in the early morning hours

Effects of angiotensin II receptor blockers on diabetic nephropathy

Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes

Effect of peroxisome proliferator-activated receptor alpha on human angiotensinogen promoter

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Increased renin production in mice with deletion of peroxisome proliferator-activated receptor-gamma in juxtaglomerular cells.

PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis

Thiazolidinediones--tools for the research of metabolic syndrome X.

Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.

Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention

P304

698730

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2010/698730

http://www.w3.org/2001/XMLSchema#string

P478

2010

http://www.w3.org/2001/XMLSchema#string

P50

Mercedes Ricote

P577

2010-06-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45102442

http://www.w3.org/2001/XMLSchema#string

P698

20613959

http://www.w3.org/2001/XMLSchema#string

P932

2896854

http://www.w3.org/2001/XMLSchema#string